[email protected]

ARCH Venture Partners

eGenesis adds Daniel Lynch to its Board as Executive Chairman along with raising $38m Series A financing led by Biomatics Capital and ARCH Venture Partners

– USA, MA – eGenesis, a biotechnology company focused on utilizing genome editing technology to make xenotransplantation a routine and lifesaving medical procedure, today announced that it raised a $38 million Series A financing co-led by Biomatics Capital and ARCH Venture Partners, with participation from Khosla Ventures, Alta Partners, Alexandria Venture Investments, Heritage Provider Network, Berggruen Holdings North America Ltd., Uprising, and Fan Ventures.… => Read more

Vividion Therapeutics announces Dr Tom Daniel to its Board as Executive Chairman along with raising $50m Series A financing

– USA, CA – Vividion Therapeutics, Inc., a biotechnology company focused on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome-wide ligand and target discovery, has been launched today.… => Read more

Nohla Therapeutics appoints Katie Fanning to its Board of Directors as CEO

– USA, WA – Nohla Therapeutics Inc. , a leading developer of universal donor cellular therapies for the treatment of patients with life threatening hematological malignancies, announced today the appointment of Kathleen Fanning as President and Chief Executive Officer and an Executive member of the Board of Directors.… => Read more

Talent4Boards Team

here the original post =>

Nohla Therapeutics announces Drs Steven Gillis and Brian Daniels to Board along with closing $43.5m Series A financing led by ARCH Venture Partners

– USA, WA – Nohla Therapeutics Inc., a biotechnology company pioneering the field of universal donor cellular therapies for treating patients with life threatening hematological disorders and cancers, today announced the initial closing of a $43.5M Series A financing round.… => Read more